Author

M. Fate

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Arballo· 1 shared A. Bhatta· 1 shared A. Maiti· 1 shared B. Cieniewicz· 1 shared B. Yu· 1 shared D. Corey· 1 shared D. Torabi· 1 shared E. Oliveira· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Arballo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Therapeutic Targeting of TIM-4-L With Engineered T Cells for Acute Myeloid Leukemia

B. Cieniewicz, E. Oliveira, M. Saxton, D. Torabi, A. Bhatta, P. Kukutla, A. Arballo, Z. Yang, B. Yu, M. Fate, H. Ning, L. Corey, A. Maiti, D. Corey

This study identifies TIM-4-L as a novel target for T cell therapy in AML, showing engineered T cells effectively eliminate AML cells in vitro and in vivo.

Clinical Cancer Research · May 1, 2024Peer-reviewedCancer Biology